scientific and microscope

Our clinical studies

We are committed to make our Clinical trials Information and Results accessible and transparent while maintaining participants privacy.

 

Clinical studies

This site provides information on both ongoing and completed clinical trials sponsored by Pierre Fabre since 2004. Real-world evidence studies which began after 01 January 2020 are also accessible.

 

Total studies

0

Current studies

0

Oncology

0

Dermatology

0

Rare diseases

0

Others

0
Show more filters
Title Therapeutic area Phase Status Start date (Planned) End date

Phase I/II open label dose escalation and dose expansion study of intravenous infusion of W0101, an antibody-drug conjugate, in patients with advanced or metastatic solid tumors. International, multicenter, open label study.

Oncology Phase I / II Completed 24 November 2017 04 October 2021

Study of efficacy and safety of V0305 solution in children suffering from Iron Deficiency Anaemia (IDA). Phase 3, multicentre, single arm open-label study

Blood Disorders Phase III Completed 06 June 2016 24 January 2019

Randomized phase III study comparing vinflunine-gemcitabine and gemcitabine-carboplatin combinations in patients ineligible to cisplatin with advanced or metastatic urothelial carcinoma

Oncology Phase III Early termination 22 February 2016 08 January 2017

Randomized Phase II study comparing single agent oral vinorelbine administered with two different schedules in patients with Advanced Non Small Cell Lung Cancer unfit for a platinum-based chemotherapy

Oncology Phase II Completed 26 October 2015 15 October 2018

Assessment of the efficacy of a new formulation of minoxidil (DC120) on hair growth, in a minizone model in androgenetic alopecia in men.

Dermatology Phase II Completed 21 August 2015 28 April 2016

Randomised Phase II Study comparing, as first-line chemotherapy, single-agent Oral Vinorelbine administered with two different schedules in patients with Advanced Breast Cancer

Oncology Phase II Completed 03 August 2015 28 September 2020

Efficacy and safety of Hemangiol solution in the treatment of high risk infantile hemangioma. A Multinational single arm study

Dermatology Phase III Completed 29 June 2015 21 February 2017

Efficacy of DC071 mouthwash (0.2% chlorhexidine digluconate) in peri-surgical care for preventing alveolar osteitis after third molar extraction

dental Phase IV Completed 30 March 2015 02 June 2016

An intra-individual randomised controlled study to evaluate the efficacy and tolerance of the product RV4421 A BS0042 in association with a moderately potent topical corticosteroid in adults with atopic dermatitis

Dermatology Phase II Completed 01 October 2014 09 July 2015

Effects of F17464 in acute exacerbation of schizophrenia

Psychiatry Phase II Completed 20 August 2014 23 November 2016

PERMIXON® 160 mg hard capsule versus placebo in the treatment n the treatment of symptomatic lower urinary tract symptoms due to benign prostatic hyperplasia

Urology Phase IV Completed 07 May 2014 27 June 2016

Phase I-II study of F17752 in patients with advanced solid tumors

Oncology Phase I / II Early termination 01 October 2013 13 October 2013

Bronchodilator properties and safety of a repeated dose of V0162 inhalation powder in asthma

Respiratory Phase II Completed 26 September 2013 30 April 2014

Clinical efficacy and safety of J022X ST in the prevention of Recurrent Upper-Respiratory Tract Infections (RURTI) in children with a high risk of recurrence

Respiratory Phase III Completed 02 September 2013 17 October 2016

Phase III study of Vinflunine plus Capecitabine versus Capecitabine alone in patients with advanced breast cancer

Oncology Phase III Completed September 2013 July 2017

Efficacy and safety study of F373280 for maintenance of sinus rhythm after electrical cardioversion in patients with persistent Atrial Fibrillation and Chronic Heart Failure

Cardiovascular Phase II Completed 20 May 2013 21 June 2017

Phase I-II study of F14512 in combination with cytarabine in patients 60 years old and older with acute myeloid leukemia

Oncology Phase I / II Early termination 09 April 2013 03 March 2017

Study of efficacy and safety of V0498 versus placebo in acute sore throat pain

Respiratory Phase III Completed 13 February 2013 25 June 2013

Emollients in the management of atopic dermatitis in children: prevention of flares

Dermatology Phase III Completed 07 February 2013 12 February 2014

Clinical and biophysics evaluation of the cutaneous modifications following the local use of a lotion containing 0,1 % of trétinoïne

Dermatology Phase IV Completed February 2013 20 February 2014

Get access to Partner's pivotal studies supporting our authorized drugs in Europe

Results from pivotal studies conducted by our partners and supporting a marketing approval for whom Pierre Fabre is the holder in Europe are shared below:

 

Melanoma

SPONSOR: PFIZER

Breast cancer 

SPONSOR: PUMA BIOTECHNOLOGY

Colorectal cancer

SPONSOR: PFIZER

Post-transplantation lymphoproliferative disease EBV+

SPONSOR: ATARA